CN1170559C - Capsule for removing heat from liver and detoxicating and its preparing process - Google Patents
Capsule for removing heat from liver and detoxicating and its preparing process Download PDFInfo
- Publication number
- CN1170559C CN1170559C CNB001178474A CN00117847A CN1170559C CN 1170559 C CN1170559 C CN 1170559C CN B001178474 A CNB001178474 A CN B001178474A CN 00117847 A CN00117847 A CN 00117847A CN 1170559 C CN1170559 C CN 1170559C
- Authority
- CN
- China
- Prior art keywords
- radix
- paeoniae rubra
- radix paeoniae
- capsule
- rhizoma coptidis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a capsule for removing heat from the liver and detoxifying and a preparation method thereof. The capsule belongs to a traditional Chinese medical preparation for treating liver diseases, is prepared from 40 to 50 portions of coptis, 15 to 25 portions of rhubarb, 20 to 30 portions of red peony root and 5 to 10 portions of jinhaisha by weight, has the functions of removing toxic heat, removing dampness by diuresis and absorbing clots, has high physiological activity, has the effects of microbic resistance, liver nourishment and acute inflammation resistance, and has a certain protective function on pathological liver tissue change.
Description
Technical field
The invention belongs to a kind of Chinese medicine preparation for the treatment of hepatic disease, particularly relate to a kind of liver heat removing toxic capsule and preparation method thereof.
Background technology
Hepatitis B is a kind of commonly encountered diseases, frequently-occurring disease, and it has become one of infectious disease of serious harm human health.At present, doctor trained in Western medicine does not still have specific medicine to the treatment hepatopathy, some so-called " hepatoprotective " actual effect is unsatisfactory, if the patient " turns to any doctor one can find when critically ill ", it is too assorted too much that medicine is used, only can increase the weight of the metabolism burden of liver, countries in the world are recognized the huge side effect that medicine brings to the mankind gradually in recent years, iatrogenic, property of medicine disease increases day by day, the chemical drugs development cost is huge, a series of problems such as medical expenses improve day by day, therefore, adopt the human green plants medicine of being yearned for, need not to experience complicated chemosynthesis process, relative low price, the Chinese patent medicine that side effect is little is the medicine that people press for.
Summary of the invention
The object of the present invention is to provide a kind of Chinese patent medicine for the treatment of acute hepatitis and diseases such as chronic hepatitis acute attack or chronic hepatitis of active stage and preparation method thereof.
Solution of the present invention is the theory according to traditional traditional Chinese medical science; in conjunction with old docter of TCM's clinical empirical summary for many years; all selecting the Chinese herbal medicine with " heat-clearing and toxic substances removing; dampness removing blood stasis dispelling " function for use is that raw material is made; skim the cream off milk, have very strong physiologically active, anti-microbial effect, choleretic effect, anti-acutely inflamed effect are arranged, also there is the certain protection effect in hepatic pathology change in organization.
Liver heat removing toxic capsule of the present invention is characterized in that it being to be made by following raw materials in weight portion:
Rhizoma Coptidis: 40-50 Radix Et Rhizoma Rhei: 15-25 Radix Paeoniae Rubra: 20-30 Spora Lygodii 5-10
The capsular formula optimization weight portion of preparation the present invention ratio range is:
Rhizoma Coptidis: 43-47 Radix Et Rhizoma Rhei: 18-22 Radix Paeoniae Rubra: 22-27 Spora Lygodii: 6-8
The capsular optimum weight part of the present invention proportioning is:
Rhizoma Coptidis: 47 Radix Et Rhizoma Rhei: 21 Radix Paeoniae Rubra: 25 Spora Lygodii: 7
Rhizoma Coptidis among the present invention is a Ranunculaceae herbaceos perennial Rhizoma Coptidis Coptis chinensisFranch. rhizome.Has heat clearing and damp drying, the function of eliminating fire and detoxication, mainly contain berberine in the Rhizoma Coptidis, secondly be coptisine, 13-methyl-.psi.-coptisine., palm leaf coculine, multiple alkaloid such as palmatine, its pharmacology has broad-spectrum antibacterial action, and can suppress leptospira, ameba, influenza virus and various pathogenic fungus.The phagocytic function that makes bark of a cork tree alkali can strengthen the white blood autumn is in vivo expanded not tip blood vessel, is brought high blood pressure down, function of gallbladder promoting, analgesic, diuresis and antitumor action.
Radix Et Rhizoma Rhei among the present invention is a polygonaceae plant Rheum officinale Rheum officinale Baill. rhizome, function with purging heat to relax the bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation, mainly contain anthraquinone derivative in the Radix Et Rhizoma Rhei, contain yellow tannic acid and related substances and fatty acid, calcium oxalate, glucose, fructose and a large amount of starch again, associativity Radix Et Rhizoma Rhei acids can increase intestinal tension force and wriggling in the Radix Et Rhizoma Rhei, and can reduce the serum urea nitrogen of rat, improve the effect of renal function.
Radix Paeoniae Rubra among the present invention is the root of Ranunculaceae herbaceos perennial Paeonia lactiflora Pall., it mainly contains paeoniflorin, peonine, peonol, organic acid, tannin, cupreol, gallic acid second fat etc., have effects such as clearing away heat and cooling blood, eliminating stasis to stop pain, convulsion, blood vessel dilating, and can antibiotic and inhibition influenza virus.
Spora Lygodii among the present invention is the perennial spore of climbing up by holding on to the drying and ripening of pteridophyta Spora Lygodii Lygodium japonicum (Thunb.) Sw. of Lygodiaceae.Have inducing diuresis for treating stranguria syndrome, inducing diuresis to remove edema effect, yellow Fructus Vitis viniferae ball, bacillus pyocyaneus, shigella flexneri and Bacillus typhi etc. are all had inhibitory action.
Liver heat removing toxic capsule of the present invention is a raw material with above-mentioned four flavors, and its production method that is prepared into the Chinese medicine capsule employing is:
1. get Rhizoma Coptidis, Radix Paeoniae Rubra two flavor medicinal material coarse powder mixing, add 12 times of water, decoct each one hour three times;
2. medical filtration, merging, concentrated after Rhizoma Coptidis, Radix Paeoniae Rubra being decocted, spray drying is with the airtight preservation of spray drying powder, standby then;
3. get Radix Et Rhizoma Rhei, Spora Lygodii pulverizing medicinal materials, cross 80 mesh sieves, standby;
4. get standby Radix Et Rhizoma Rhei, Spora Lygodii two flavor medicated powder and standby Rhizoma Coptidis, Radix Paeoniae Rubra spray drying powder mix homogeneously, fill zero capsule and get product.
The dosage that the present invention is used for the treatment of is adult every day three times, and each four, course of treatment of acute hepatitis A is one month; Course of treatment of acute hepatitis b is two months.
The present invention has heat-clearing and toxic substances removing, dampness removing blood stasis dispelling and rushes down the therapeutic effect that protects the liver down, and the present invention is a pure Chinese medicinal preparation, taking convenience, have no side effect, the cure rate of a course of treatment reaches 90%.
Claims (4)
1, a kind of liver heat removing toxic capsule is characterized in that it being to be made by following raw materials in weight portion: Rhizoma Coptidis: 40-50 Radix Et Rhizoma Rhei: 15-25 Radix Paeoniae Rubra: 20-30 Spora Lygodii 5-10.
2, liver heat removing toxic capsule according to claim 1 is characterized in that the weight portion ratio range of each raw material is:
Rhizoma Coptidis: 43-47 Radix Et Rhizoma Rhei: 18-22 Radix Paeoniae Rubra: 22-27 Spora Lygodii: 6-8.
3, liver heat removing toxic capsule according to claim 1 is characterized in that the weight portion proportioning of each raw material is: Rhizoma Coptidis: 47 Radix Et Rhizoma Rhei: 21 Radix Paeoniae Rubra: 25 Spora Lygodii: 7.
4, a kind of method for preparing the described liver heat removing toxic capsule of claim 1 is characterized in that may further comprise the steps:
(1) gets Rhizoma Coptidis, Radix Paeoniae Rubra two flavor medicinal material coarse powder mixing, add 12 times of water, decoct each one hour three times;
(2) medical filtration, the merging after Rhizoma Coptidis, Radix Paeoniae Rubra are decocted, concentrate, spray drying then, the airtight preservation of dry powder of will spraying, standby;
(3) get Radix Et Rhizoma Rhei, Spora Lygodii pulverizing medicinal materials, cross 80 mesh sieves, standby;
(4) get standby Radix Et Rhizoma Rhei, sea sand gold two flavor medicated powder and standby Rhizoma Coptidis, Radix Paeoniae Rubra spray drying powder mix homogeneously, fill zero capsule and get product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001178474A CN1170559C (en) | 2000-05-25 | 2000-05-25 | Capsule for removing heat from liver and detoxicating and its preparing process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001178474A CN1170559C (en) | 2000-05-25 | 2000-05-25 | Capsule for removing heat from liver and detoxicating and its preparing process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1325709A CN1325709A (en) | 2001-12-12 |
CN1170559C true CN1170559C (en) | 2004-10-13 |
Family
ID=4587085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001178474A Expired - Fee Related CN1170559C (en) | 2000-05-25 | 2000-05-25 | Capsule for removing heat from liver and detoxicating and its preparing process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1170559C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101618085B (en) * | 2008-07-01 | 2011-09-28 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition for treating liver and gallbladder dampness-heat disease and preparation method thereof |
CN101683404B (en) * | 2008-09-22 | 2012-06-13 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition for treating dampness and heat in liver and gallbladder and preparation method thereof |
CN102552518A (en) * | 2011-12-31 | 2012-07-11 | 沈阳药科大学 | Application of four traditional Chinese medicines in relieving liver and kidney toxicity |
-
2000
- 2000-05-25 CN CNB001178474A patent/CN1170559C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1325709A (en) | 2001-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102973862B (en) | Chinese medicine preparation for treating skin itch | |
CN101549113A (en) | Traditional Chinese medicine composition for treating urinary system stones and preparation method thereof | |
CN1840115A (en) | Acne-treating medicinal soap and preparation method thereof | |
CN1170559C (en) | Capsule for removing heat from liver and detoxicating and its preparing process | |
CN104606385A (en) | Traditional Chinese medicine preparation for treating paronychia | |
CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN101036706A (en) | Wine for promoting blood circulation by removing blood stasis and for eliminating rheumatism | |
CN1298376C (en) | Pure Chinese medicine capsule for treating psora and its preparation technology | |
CN106421572A (en) | Traditional Chinese medicine preparation for treating animal theileriosis and preparation method thereof | |
CN101816714A (en) | Chinese traditional medicine for promoting fracture healing and preparation method thereof | |
CN1404868A (en) | Chinese medicinal preparation for treating pyretic stranguria | |
CN1616011A (en) | Medicinal composition for treating ulcerative colitis and its preparing method | |
CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
CN110585300A (en) | Medicine for treating arthralgia-synadrome and preparation method thereof | |
CN111358906A (en) | Traditional Chinese medicine composition suitable for exogenous diseases | |
CN110251564B (en) | External medicine for treating gouty arthritis and preparation method thereof | |
CN1063078C (en) | Chinese herbal decoction as oral liquid and its preparation and application | |
CN1158093C (en) | Medicine composition containing yak bone for treating rhenmatism and method for making same | |
CN1238012C (en) | Chinese medicine in the form of spray for treating infection of tonsil | |
CN101837107A (en) | Traditional Chinese medicine for curing acute and chronic cholecystitis, biliary tract infection, gall-stone, and biliary tract postoperative syndromes | |
CN1951435A (en) | Pills having blood pressure lowering and vessel relaxing functions | |
CN1840146A (en) | Medicament for treating vitiligo | |
CN1814122A (en) | Medicine for treating osteoporosis and preparing method | |
CN1686288A (en) | Shenxian capsulea nd its preparation technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |